United States · FDA National Drug Code directory
Zolgensma
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71894-142_7039f121-a56c-49ba-bca9-28b7bc6afbcb
- Product NDC
- 71894-142
- Form
- KIT
- Composition / generic term
- onasemnogene abeparvovec-xioi
- Labeler
- Novartis Innovative Technologies Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20190524
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (71894-142-10) * 8.3 mL in 1 VIAL (71894-115-01) * 1 mL in 1 POUCH * 5.5 mL in 1 VIAL (71894-110-01) · 71894-142-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →